BR101

· BioRay Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BR101, covering 2025-11-21 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: BR101 in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]